Related references
Note: Only part of the references are listed.Outcomes of neoadjuvant therapy for cholangiocarcinoma: A review of existing evidence assessing treatment response and R0 resection rate
Viet H. Le et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Propensity Score Survival Analysis Supporting Use in Patients with High-Risk Disease
Ovie Utuama et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial
Thorsten O. Goetze et al.
BMC CANCER (2020)
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma
Sara Massironi et al.
CELLS (2020)
Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials
Satoshi Nara et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)
Incident Cases Captured in the National Cancer Database Compared with Those in US Population Based Central Cancer Registries in 2012-2014
Katherine Mallin et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis
Siddhartha Yadav et al.
EJSO (2019)
Surgery for cholangiocarcinoma
Umberto Cillo et al.
LIVER INTERNATIONAL (2019)
Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study
Jean-Marc Phelip et al.
DIGESTIVE AND LIVER DISEASE (2019)
The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival
U. F. Wellner et al.
SURGERY TODAY (2017)
Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18243 patients
Linda M. Youngwirth et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
Jang Han Jung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Using the National Cancer Database for Outcomes Research
Daniel J. Boffa et al.
JAMA ONCOLOGY (2017)
Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer
Shogo Kobayashi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Neoadjuvant chemoradiation therapy for cholangiocarcinoma to improve R0 resection rate: The first report of phase II study.
Yu Katayose et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer
Ryan P. Merkow et al.
ANNALS OF SURGERY (2014)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review
Jan Grendar et al.
HPB (2014)
Effect of Postoperative Complications on Adjuvant Chemotherapy Use for Stage III Colon Cancer
Ryan P. Merkow et al.
ANNALS OF SURGERY (2013)
Neoadjuvant therapy in resectable pancreatic cancer: A critical review
Carmen Belli et al.
CANCER TREATMENT REVIEWS (2013)
Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins
Evan S. Glazer et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Prognostic Factors After Surgical Resection for Intrahepatic, Hilar, and Distal Cholangiocarcinoma
Yoshiaki Murakami et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
RADIOTHERAPY IN THE TREATMENT OF PATIENTS WITH UNRESECTABLE EXTRAHEPATIC CHOLANGIOCARCINOMA
A. Paiman Ghafoori et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
The National Cancer Data Base: A powerful initiative to improve cancer care in the United States
Karl Y. Bilimoria et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Trends in survival after surgery for cholangiocarcinoma: A 30-year population-based SEER database analysis
Hari Nathan et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2007)
Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution
Michelle L. DeOliveira et al.
ANNALS OF SURGERY (2007)
Share Paper
